Home » Topics » BioWorld Science

BioWorld Science
RSS

Potentiation of insulin action by two different IR activators in insulin-resistant cells

Oct. 23, 2001

Long-term tamsulosin has sustained efficacy, safety in LUTS/BPH

Oct. 23, 2001

Novel products moving successfully through the pipeline at Millennium

Oct. 23, 2001

Clinical development update provided for CYC-202, a CDK2 inhibitor

Oct. 23, 2001

R-105266 emerges from preclinical testing as safe and effective antiulcer agent

Oct. 23, 2001

Approval of Xeloda for treatment of breast cancer recommended in E.U.

Oct. 23, 2001

Antex concludes Phase I of SBIR grant from U.S. Army

Oct. 23, 2001

Helinx technology successfully inactivates Trypanosoma cruzi

Oct. 23, 2001

CV Therapeutics discovers several series of partial fatty acid oxidation inhibitors

Oct. 22, 2001

Chemokine receptor modulators designed by AstraZeneca team

Oct. 22, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...